SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-17-003464
Filing Date
2017-06-05
Accepted
2017-06-05 16:00:18
Documents
20
Period of Report
2017-06-05
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_060517.htm 8-K 17781
2 EXHIBIT 99.1 exh_991.htm EX-99.1 15760
3 EXHIBIT 99.2 exh_992.htm EX-99.2 25568
4 GRAPHIC exh992_01.jpg GRAPHIC 88139
5 GRAPHIC exh992_02.jpg GRAPHIC 164490
6 GRAPHIC exh992_03.jpg GRAPHIC 147596
7 GRAPHIC exh992_04.jpg GRAPHIC 96338
8 GRAPHIC exh992_05.jpg GRAPHIC 103114
9 GRAPHIC exh992_06.jpg GRAPHIC 108277
10 GRAPHIC exh992_07.jpg GRAPHIC 85072
11 GRAPHIC exh992_08.jpg GRAPHIC 90006
12 GRAPHIC exh992_09.jpg GRAPHIC 79691
13 GRAPHIC exh992_10.jpg GRAPHIC 94110
14 GRAPHIC exh992_11.jpg GRAPHIC 96284
15 GRAPHIC exh992_12.jpg GRAPHIC 87683
16 GRAPHIC exh992_13.jpg GRAPHIC 117697
17 GRAPHIC exh992_14.jpg GRAPHIC 98368
18 GRAPHIC exh992_15.jpg GRAPHIC 95381
19 GRAPHIC exh992_16.jpg GRAPHIC 91028
20 GRAPHIC exh992_17.jpg GRAPHIC 127443
  Complete submission text file 0001171843-17-003464.txt   2476672
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37719 | Film No.: 17891140
SIC: 2834 Pharmaceutical Preparations